Wearable monitoring for med-surg and step-down
MEMO turns step-down and acute care floors into continuously monitored beds. Our wearable patient monitor and real-time AI flag clinical deterioration up to 24 hours in advance and identify patients ready for early discharge, so hospitals shorten average length of stay, free bed capacity, and reduce readmissions.
Meet MEMO
One wireless patch captures continuous, medical-grade vital signs in the hospital and at home after discharge. No bedside monitor to install, no infrastructure needed, and no wires to manage.
Standard
Add-on
Why MEMO
Most patients on the floor get a vital signs check every four to eight hours. MEMO monitors continuously, so deterioration between checks does not go unnoticed.
MEMO's AI analyzes its own signal and alerts only on genuine clinical deterioration, cutting false alarms and the alarm fatigue that comes with them.
By identifying patients ready for discharge and continuing to monitor them at home, MEMO helps reduce length of stay, free bed capacity, and prevent readmissions.
Across the care continuum
Spot checks on med-surg and step-down floors leave gaps where deterioration goes unseen and add to nurse workload. MEMO monitors continuously, giving care teams real-time visibility and earlier warning of a patient's decline.
Discharge is the highest-risk handoff in the stay. The same patch continues at home, so monitoring is not interrupted, supporting earlier discharge and a safer recovery.
Remote monitoring at home detects complications early and reduces avoidable readmissions, while keeping care teams informed between visits.
Proven across APAC
MEMO's wearable ECG monitoring is in daily use across top hospitals in Korea, Japan, and Vietnam.
of Korea's tertiary hospitals monitor with MEMO
wearable ECG monitoring in Korea
APAC countries in clinical use today
Product roadmap
Each stage builds on technology already in clinical use. We add capability once the layer beneath it has earned its place.
Continuous cardiac monitoring in a wearable patch, the market leader across Korea's leading hospitals and FDA 510(k) cleared for the US.
Continuous multiparameter monitoring with AI that predicts clinical deterioration and discharge readiness, built on continuous ECG as a core input.
Early prediction of sepsis, myocardial infarction, and respiratory failure, learned from MEMO's own continuous data.
Our vision
Continuous monitoring should not be reserved for the ICU.
We are extending real-time awareness to every floor and into the home, so clinical deterioration is caught earlier, wherever the patient is.
Who it's for
CMOs and Quality
Earlier detection of deterioration and measurable gains in acute-care outcomes.
Nurse leaders
Continuous coverage with fewer false alarms and no added bedside hardware.
Hospital finance
Shorter length of stay, higher throughput, and fewer readmissions under DRG.
Investors
A proven APAC leader bringing continuous monitoring and AI to the US.
Request a demo or ask about a pilot. Our team follows up within two business days.